Table 1.

Peer-reviewed studies to date (N=18) reporting effectiveness of nontargeted HIV screening in EDs since 2006, stratified by consent method.

Authors	Year Published	Setting*	External Staff	Eligible Patients,	Offered Testing		Patients Tested		Confirmed Positive
				N†	N1	%	N2	%	N3	%
Opt-in consent
Silva et al21	2007	U, I	Y	3,030	NR	–	1,428	47	8	0.56
Mehta et al22	2007	U, A, I	Y	NR	2,924	–	1,428	–	8	0.56
Walensky et al23	2008	U, A	Y	2,356	1,397	59	854	36	5	0.59
White et al24	2009	U, A, I	N	118,324	45,159	38	7,923	7	55	0.69
White et al25‡	2011	U, A, I	N	23,236	6,479	28	4,053	17	8	0.20§
d’Almeida et al26	2011	MI	N	78,411	20,962	27	12,754	16	18	0.14§
Wilbur et al27	2011	U, A, I	Y	5,794	1,484	26	1,121	19	5	0.45
Casalino et al28	2012	MI	N	183,957	11,401	6	7,215	4	40	0.55§
Haukoos et al29‡	2012	U, A, I	N	5,985	5,781	97	389	6	0	0
Hack et al30	2013	U, A, P	Y	2,645	300	11	224	8	0	0
Haukoos et al31	2013	U, A, I	N	29,510	19,634	67	3,591	12	7	0.20§
Lyons et al32	2013	U, A, I	Y	5,501	4,692	85	1,911	35	6	0.31§
Median						33		16		0.20§
Range						6–97		4–47		0.14–0.55§
Opt-out consent
Brown et al33	2007	U, A, I	Y	13,240	4,187	32	2,486	19	9	0.36
Haukoos et al34	2010	U, A, I	N	28,043	NR	–	6,933	25	15	0.22§
Sattin et al35||	2011	U, A, I	Y	13,035	9,343	72	8,504	65	35	0.41
Wheatley et al36	2011	U, A	Y	NR	8,922	–	7,616	–	129	1.7
White et al25‡	2011	U, A, I	N	26,757	20,280	76	4,679	18	21	0.45§
Hoxhaj et al37	2011	U, A, I	N	24,686	NR	–	14,093	57	80	0.57§
Haukoos et al29‡	2012	U, A, I	N	6,842	6,602	97	886	13	2	0.23§
Geren et al20	2014	U, A, I	N	71,556	55,500	78	27,952	39	78	0.28
Median						76		25		0.34§
Range						32–97		13–65		0.22–0.57§

–, Undefined; U, urban; I, Level I trauma center; NR, not reported; A, academic; MI, multiple institutions; P, pediatric only.

^*Setting.

^†Eligibility varied by study.

^‡Reported in the same study.

^§Specifically indicates new HIV diagnoses.

^||Reports more complete results that overlap with those of a previous publication.⁴⁴